Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$636M |
| 2 |
UnitedHealth
UNH
|
+$635M |
| 3 |
Estee Lauder
EL
|
+$632M |
| 4 |
AbbVie
ABBV
|
+$466M |
| 5 |
PayPal
PYPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$559M |
| 2 |
SHPG
Shire pic
SHPG
|
+$464M |
| 3 |
Amazon
AMZN
|
+$458M |
| 4 |
Ulta Beauty
ULTA
|
+$439M |
| 5 |
Alibaba
BABA
|
+$397M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.26% |
| 2 | Healthcare | 15.72% |
| 3 | Consumer Discretionary | 14.97% |
| 4 | Communication Services | 12.99% |
| 5 | Financials | 11.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
UnitedHealth
UNH
$353B
| $1.09B | 1.11% |
5,541,977
+3,289,470
| +146% | +$635M |
|
27
Albemarle
ALB
$16.2B
| $1.06B | 1.09% |
7,797,076
+1,375,546
| +21% | +$164M |
|
28
Tesla
TSLA
$1.38T
| $985M | 1.01% |
43,316,880
-1,723,395
| -4% | -$39.8M |
|
29
Vertex Pharmaceuticals
VRTX
$137B
| $915M | 0.94% |
6,017,766
+962,644
| +19% | +$145M |
|
30
Parker-Hannifin
PH
$125B
| $897M | 0.92% |
5,127,665
-898,775
| -15% | -$148M |
|
|
RHT
31
DELISTED
Red Hat Inc
RHT
| $887M | 0.91% |
8,001,251
-1,349,933
| -14% | -$138M |
|
|
AGN
32
DELISTED
Allergan plc
AGN
| $872M | 0.89% |
4,256,419
-1,242,800
| -23% | -$289M |
|
33
Home Depot
HD
$329B
| $813M | 0.83% |
4,973,452
-1,095,016
| -18% | -$168M |
|
34
Illumina
ILMN
$32.6B
| $808M | 0.83% |
4,171,029
-608,962
| -13% | -$113M |
|
35
Workday
WDAY
$50.6B
| $808M | 0.83% |
7,668,832
-185,399
| -2% | -$19.1M |
|
36
Crown Castle
CCI
$32.4B
| $804M | 0.82% |
8,042,148
+236,039
| +3% | +$24.1M |
|
|
ALXN
37
DELISTED
Alexion Pharmaceuticals
ALXN
| $748M | 0.77% |
5,332,636
+4,682,336
| +720% | +$636M |
|
|
CXO
38
DELISTED
CONCHO RESOURCES INC.
CXO
| $743M | 0.76% |
5,640,195
-398,215
| -7% | -$47.9M |
|
39
Corpay
CPAY
$26.8B
| $689M | 0.71% |
4,453,791
-82,804
| -2% | -$12.2M |
|
40
Monster Beverage
MNST
$91.8B
| $666M | 0.68% |
48,213,900
+272,164
| +0.6% | +$3.67M |
|
|
41
Estee Lauder
EL
$37.4B
| $664M | 0.68% |
+6,161,274
| New | +$632M |
|
42
Texas Instruments
TXN
$236B
| $596M | 0.61% |
6,647,208
-1,027,615
| -13% | -$84.5M |
|
43
Costco
COST
$419B
| $583M | 0.6% |
3,548,179
-1,450,520
| -29% | -$228M |
|
|
SPLK
44
DELISTED
Splunk Inc
SPLK
| $582M | 0.6% |
8,759,270
-220,011
| -2% | -$13.8M |
|
45
FedEx
FDX
$78.3B
| $564M | 0.58% |
2,502,242
-600,653
| -19% | -$128M |
|
|
46
AbbVie
ABBV
$451B
| $544M | 0.56% |
+6,126,689
| New | +$466M |
|
47
Regeneron Pharmaceuticals
REGN
$81.8B
| $536M | 0.55% |
1,199,747
-93,116
| -7% | -$44.3M |
|
|
48
PayPal
PYPL
$45.9B
| $482M | 0.49% |
+7,526,740
| New | +$451M |
|
49
Halliburton
HAL
$30.1B
| $402M | 0.41% |
8,726,712
+105,046
| +1% | +$4.4M |
|
50
PG&E
PCG
$36.6B
| $376M | 0.39% |
5,520,849
-52,795
| -0.9% | -$3.62M |
|
Similar funds
Jennison Associates's Q3 2017 Portfolio in Review
As of Q3 2017, Jennison Associates held 727 positions worth $97.6B, up 3.6% from $94.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jennison Associates withdrew a net $3.46B in Q3 2017, closing 79 positions and reducing 330 holdings. Its most notable exit was O'Reilly Automotive, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Estee Lauder worth $664M.
- Jennison Associates's largest Q3 2017 buy was Estee Lauder: 6,161,274 shares worth $664M.
- Jennison Associates added most to Alexion Pharmaceuticals in Q3 2017, an estimated $636M increase.
- Jennison Associates's biggest Q3 2017 reduction was Shire pic, cutting an estimated $464M.
- Jennison Associates fully exited O'Reilly Automotive in Q3 2017, selling an estimated $559M.
- Jennison Associates's ten largest holdings make up 28% of its $97.6B portfolio in Q3 2017.
- Jennison Associates opened 90 new positions and closed 79 in Q3 2017.
- Jennison Associates's portfolio value rose 3.6% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2017, filed 3 Nov 2017.